CipherBio Weekly Digest: Week of Jan 20 – 26 2022
This week life science growth continues and we report a total of $1.7B in deals and 136 new events, including M&A, IPOs and Funds Raised. Additionally, we added 51 new companies and 20 new investors to our CipherBio PRO platform.
Featured Top Deals
Zoi raises $23M in Seed round led by Jean-Claud Marian and Stephane Bancel. In Series A, Cellino raises $80M led by Leaps by Bayer. Metagenomi, a gene-editing company, gets $175M in Series B round led by PFM Health Sciences. Distalmotion receives $90M / Series E led by Revival Healthcare Capital and joined by 415 Capital.
The big news this week UCB Pharma acquires Zogenix for $1.8 billion. Psychedelic-focused drug company Eleusis is merging with Silver Spike Acquisition Corp. II, a special purposes acquisition company, and going to the Nasdaq with a deal of $288 million.
San Francisco-basedBuilders VC raises $250M in Builders Fund II from undisclosed investors and will deploy some of that capital into Canadian startups. eHealth Ventures, a consortium conceived to provide incubation services to promising early-stage healthcare technology companies, raises $30 million in eHV Advanced Fund.
51 Life Science Companies Added
This week we added 51 new life science companies and 20 new investors to our platform showing unprecedented activity.
To get all the latest life science deals and VC funding data delivered straight to your inbox weekly become a CipherBio PRO member.